1. Chaperon, Mayeul, Pacheco, Yves, Maucort-Boulch, Delphine, Calender, Alain, Seve, Pascal. 2019. BTNL2 gene polymorphism and sarcoid uveitis. In The British journal of ophthalmology, 103, 1690-1694. doi:10.1136/bjophthalmol-2018-312949. https://pubmed.ncbi.nlm.nih.gov/30872286/
2. Du, Yanyun, Peng, Qianwen, Cheng, Du, Zhang, Zhanguo, Wang, Chenhui. 2022. Cancer cell-expressed BTNL2 facilitates tumour immune escape via engagement with IL-17A-producing γδ T cells. In Nature communications, 13, 231. doi:10.1038/s41467-021-27936-8. https://pubmed.ncbi.nlm.nih.gov/35017553/
3. Morais, António, Lima, Bruno, Peixoto, Maria José, Marques, Agostinho, Delgado, Luís. 2012. BTNL2 gene polymorphism associations with susceptibility and phenotype expression in sarcoidosis. In Respiratory medicine, 106, 1771-7. doi:10.1016/j.rmed.2012.08.009. https://pubmed.ncbi.nlm.nih.gov/23017494/
4. Tong, Xiang, Ma, Yao, Niu, Xundong, Peng, Shifeng, Fan, Hong. . The BTNL2 G16071A gene polymorphism increases granulomatous disease susceptibility: A meta-analysis including FPRP test of 8710 participants. In Medicine, 95, e4325. doi:10.1097/MD.0000000000004325. https://pubmed.ncbi.nlm.nih.gov/27472712/
5. Fitzgerald, Liesel M, Kumar, Akash, Boyle, Evan A, Shendure, Jay, Stanford, Janet L. 2013. Germline missense variants in the BTNL2 gene are associated with prostate cancer susceptibility. In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 22, 1520-8. doi:10.1158/1055-9965.EPI-13-0345. https://pubmed.ncbi.nlm.nih.gov/23833122/
智鼠故事 
